<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Braz J Med Biol Res</journal-id>
      <journal-id journal-id-type="iso-abbrev">Braz. J. Med. Biol. Res</journal-id>
      <journal-title-group>
        <journal-title>Brazilian Journal of Medical and Biological Research</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0100-879X</issn>
      <issn pub-type="epub">1414-431X</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Medicina Tropical</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22570089</article-id>
      <article-id pub-id-type="pmc">3854271</article-id>
      <article-id pub-id-type="publisher-id">S0100-879X2012007500073</article-id>
      <article-id pub-id-type="doi">10.1590/S0100-879X2012007500073</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Interleukin-10-dependent down-regulation of interferon-gamma response to <italic>Leishmania</italic> by <italic>Mycobacterium leprae</italic> antigens during the clinical course of a coinfection</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Azeredo-Coutinho</surname>
            <given-names>R.B.G.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matos</surname>
            <given-names>D.C.S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nery</surname>
            <given-names>J.A.C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Valete-Rosalino</surname>
            <given-names>C.M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mendon&#xE7;a</surname>
            <given-names>S.C.F.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1</label>Laborat&#xF3;rio de Imunoparasitologia, Instituto Oswaldo Cruz, Funda&#xE7;&#xE3;o Oswaldo Cruz, Rio de Janeiro, RJ, Brasil</aff>
        <aff id="aff2"><label>2</label>Laborat&#xF3;rio de Tecnologia Imunol&#xF3;gica, Instituto de Tecnologia em Imunobiol&#xF3;gicos, Funda&#xE7;&#xE3;o Oswaldo Cruz, Rio de Janeiro, RJ, Brasil</aff>
        <aff id="aff3"><label>3</label>Centro de Refer&#xEA;ncia Nacional em Hansen&#xED;ase, Instituto Oswaldo Cruz, Funda&#xE7;&#xE3;o Oswaldo Cruz, Rio de Janeiro, RJ, Brasil</aff>
        <aff id="aff4"><label>4</label>Departamento de Doen&#xE7;as Infecciosas, Instituto de Pesquisa Cl&#xED;nica Evandro Chagas, Funda&#xE7;&#xE3;o Oswaldo Cruz, Rio de Janeiro, RJ, Brasil</aff>
      </contrib-group>
      <author-notes>
        <corresp>Correspondence: R.B.G. Azeredo-Coutinho, Laborat&#xF3;rio de Imunoparasitologia, Instituto Oswaldo Cruz, Fiocruz, Av. Brasil, 4365, 21045-900 Rio de Janeiro, RJ, Brasil. Fax: +55-21-2290-0479. E-mail: <email>coutinhob@ymail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>5</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>7</month>
        <year>2012</year>
      </pub-date>
      <volume>45</volume>
      <issue>7</issue>
      <fpage>632</fpage>
      <lpage>636</lpage>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>10</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>3</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p id="para1">We have described a case of a patient with an intriguing association of mucocutaneous leishmaniasis with lepromatous leprosy, two opposite polar forms of these spectral diseases. In the present follow-up study, we investigated the effect of the addition of <italic>Mycobacterium leprae</italic> antigens on interferon-gamma (IFN-&#x3B3;) production in <italic>Leishmania</italic> antigen-stimulated cultures of peripheral blood mononuclear cells (PBMC) from this patient. For this purpose, PBMC cultures were stimulated with crude <italic>L. braziliensis</italic> and/or <italic>M. leprae</italic> whole-cell antigen extracts or with concanavalin A. In some experiments, neutralizing anti-human interleukin (IL)-10 antibodies were added to the cultures. IFN-&#x3B3; and IL-10 levels in culture supernatants were measured by ELISA. During active leprosy, <italic>M. leprae</italic> antigens induced 72.3% suppression of the IFN-&#x3B3; response to <italic>L. braziliensis</italic> antigen, and this suppression was abolished by IL-10 neutralization. Interestingly, the suppressive effect of <italic>M. leprae</italic> antigen was lost after the cure of leprosy and the disappearance of this effect was accompanied by exacerbation of mucosal leishmaniasis. Considered together, these results provide evidence that the concomitant lepromatous leprosy induced an IL-10-mediated regulatory response that controlled the immunopathology of mucosal leishmaniasis, demonstrating that, in the context of this coinfection, the specific immune response to one pathogen can influence the immune response to the other pathogen and the clinical course of the disease caused by it. Our findings may contribute to a better understanding of the <italic>Leishmania/M. leprae</italic> coinfection and of the immunopathogenesis of mucosal leishmaniasis.</p>
      </abstract>
      <kwd-group>
        <kwd>Interferon-gamma</kwd>
        <kwd>Interleukin-10</kwd>
        <kwd>Mucocutaneous leishmaniasis</kwd>
        <kwd>Lepromatous leprosy</kwd>
        <kwd>
          <italic>Leishmania braziliensis</italic>
        </kwd>
        <kwd>
          <italic>Mycobacterium leprae</italic>
        </kwd>
      </kwd-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="0"/>
        <ref-count count="22"/>
        <page-count count="5"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p id="para2">Leprosy and American tegumentary leishmaniasis are both caused by intracellular organisms. These diseases exhibit similar spectra of clinical forms, which are dependent on antigen-specific cell-mediated immunity. Diffuse cutaneous leishmaniasis and lepromatous leprosy are considered to be the anergic pole. These clinical forms have been associated with high expression of interleukin (IL)-10 and low expression of interferon (IFN)-&#x3B3; (<xref ref-type="bibr" rid="B01">1</xref>,<xref ref-type="bibr" rid="B02">2</xref>). At the other end of the spectrum, mucosal leishmaniasis and tuberculoid leprosy are associated with a conspicuous cell-mediated immune response in which proinflammatory cytokines, such as IFN-&#x3B3;, predominate (<xref ref-type="bibr" rid="B03">3</xref>,<xref ref-type="bibr" rid="B04">4</xref>). Although the immunopathogenesis of these diseases has been extensively investigated, there are very few immunological studies on leishmaniasis/leprosy coinfection, especially in HIV-negative patients (<xref ref-type="bibr" rid="B05">5</xref>,<xref ref-type="bibr" rid="B06">6</xref>). We have previously described an unusual association of mucosal leishmaniasis and lepromatous leprosy, opposite clinical forms in the immunopathological spectra of these diseases, and have characterized the cytokine response to <italic>Leishmania</italic> and <italic>Mycobacterium leprae</italic> antigens during coinfection. Although the stimulation of peripheral blood mononuclear cells (PBMC) with <italic>Leishmania</italic> and <italic>M. leprae</italic> antigens induced comparable levels of tumor necrosis factor (TNF)-&#x3B1;, IL-5 and IL-10, the IFN-&#x3B3; response to <italic>Leishmania</italic> antigens was extremely high while the response to <italic>M. leprae</italic> antigens was nearly absent (<xref ref-type="bibr" rid="B06">6</xref>). The contrasting responses to <italic>Leishmania</italic> and <italic>M. leprae</italic> antigens seen in this patient, leading to divergent polar forms of leishmaniasis and leprosy, prompted us to investigate a possible effect of the immune response to one infection on the course of the other. Thus, we evaluated the effect of the addition of <italic>M. leprae</italic> antigens on IFN-&#x3B3; production in <italic>L. braziliensis</italic> antigen-stimulated PBMC cultures.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>Material and Methods</title>
      <sec>
        <title>Case presentation</title>
        <p id="para3">A 46-year-old male patient presented with a clinically active mucosal leishmaniasis and lepromatous leprosy coinfection, the clinical picture of which has been previously described in detail (<xref ref-type="bibr" rid="B06">6</xref>). The diagnosis of polar lepromatous leprosy was based on positive results from smears of skin samples from the earlobes, elbows, and knees, with an average bacterial index of 4+ with Ziehl-Nielsen staining. Mucosal leishmaniasis was diagnosed by isolation of <italic>Leishmania</italic> from the nasal mucosal lesion. The isolated parasites were characterized as <italic>Leishmania braziliensis</italic> by isoenzyme analysis (<xref ref-type="bibr" rid="B07">7</xref>). The patient was treated for leishmaniasis with meglumine antimoniate for 30 days with a low-dose schedule of 5&#x2005;mg/kg per day of pentavalent antimony and for leprosy with a multidrug therapy regimen (<xref ref-type="bibr" rid="B06">6</xref>) with 24 monthly supervised doses. Leprosy treatment was started 10 months before the beginning of leishmaniasis therapy and ended 13 months after its completion. Nine months after diagnosis, the leishmaniasis lesion was considered to be healed, leaving partial mutilation of the nose. Relapse was noticed 13 months after cure of the mucosal lesion, with erosion of the nose and large edema and infiltration of the nose and lips extending to the malar region. On that occasion, <italic>Leishmania</italic> parasites were again isolated from a biopsy specimen from the nasal lesion, but the patient had no clinical sign of leprosy and skin smears obtained bilaterally from earlobes, elbows, and knees showed a bacterial index of 0 (zero).</p>
      </sec>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p id="para4">Venous blood samples were obtained twice before and twice after the cure of leprosy. The patient was clinically cured of mucosal leishmaniasis when the experiments were performed before the cure of leprosy. PBMC were obtained, cultured and stimulated with crude <italic>L. braziliensis</italic> and/or <italic>M. leprae</italic> whole-cell antigen extracts (50&#x2005;mg/mL) or with concanavalin A (ConA) (20&#x2005;mg/mL). The antigen extracts were prepared as previously described (<xref ref-type="bibr" rid="B06">6</xref>). Briefly, <italic>L. braziliensis</italic> (WHO reference strain MHOM/BR/75/2903) promastigotes were separately cultured in Novy-McNeal-Nicolle medium (<xref ref-type="bibr" rid="B08">8</xref>), supplemented with RPMI 1640 medium (Sigma, USA) and 10% heat-inactivated fetal calf serum (Sigma). Stationary phase promastigotes were washed three times by centrifugation at 900&#x2005;<italic>g</italic> for 10&#x2005;min at 4&#xB0;C in PBS and were disrupted by 10 repeated cycles of freezing and thawing, followed by ultrasonication (Ultra-tip Labsonic System; Lab-Line, USA) at 40 watts for 15&#x2005;min in an ice bath. An irradiated, armadillo-derived whole <italic>M. leprae</italic> antigen preparation (2 &#xD7; 10<sup>9</sup> bacteria/mg; kindly provided by Dr. M.C. Pessolani, Laborat&#xF3;rio de Hansen&#xED;ase, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil) was sonicated according to the same protocol as used for the <italic>Leishmania</italic> antigen extracts. Previous publications have shown that the antigen extracts used in this study stimulate production of TNF-&#x3B1; and IL-10 in PBMC cultures from healthy subjects (<xref ref-type="bibr" rid="B09">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>). The antigen concentration in each preparation was adjusted to 1&#x2005;mg/mL protein nitrogen. All samples were kept at -20&#xB0;C until use.</p>
      <p id="para5">Neutralizing anti-human IL-10 antibodies (BD Pharmingen, USA) were added to some cultures at a final concentration of 50 &#xB5;g/mL, concomitantly with the antigens. IFN-&#x3B3; and IL-10 levels in PBMC culture supernatants were estimated by ELISA as previously described (<xref ref-type="bibr" rid="B06">6</xref>). The results are reported as the differences between the mean cytokine levels in stimulated and unstimulated (with medium alone) triplicate cultures. The detection limit of the assays was 8&#x2005;pg/mL for both IFN-&#x3B3; and IL-10. This research protocol was carried out in compliance with the Helsinki Declaration, and was approved by the Ethics Review Committee of Instituto de Pesquisa Cl&#xED;nica Evandro Chagas, Funda&#xE7;&#xE3;o Oswaldo Cruz, Brazilian Ministry of Health, under the reference No. CAAE 0016.0.009.000-02.</p>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p id="para6"><xref ref-type="fig" rid="f01">Figure 1</xref> shows the results of representative experiments performed before (<xref ref-type="fig" rid="f01">Figure 1A and C</xref>) and after (<xref ref-type="fig" rid="f01">Figure 1B and D</xref>) the cure of leprosy. On both occasions, the patient's PBMC produced high levels of IFN-&#x3B3; in response to the <italic>L. braziliensis</italic> antigen extract and no IFN-&#x3B3; response when stimulated with <italic>M. leprae</italic> antigens (<xref ref-type="fig" rid="f01">Figure 1A and B</xref>). The neutralization of IL-10 (<xref ref-type="fig" rid="f01">Figure 1C and D</xref>) did not reverse the inability of the patient's cells to secrete IFN-&#x3B3; in response to <italic>M. leprae</italic> (<xref ref-type="fig" rid="f01">Figure 1A and B</xref>). The levels of IFN-&#x3B3; and IL-10 in unstimulated cultures were 0 (<xref ref-type="fig" rid="f01">Figure 1A</xref>), 39.3&#x2005;pg/mL (<xref ref-type="fig" rid="f01">Figure 1B</xref>), 130.9&#x2005;pg/mL (<xref ref-type="fig" rid="f01">Figure 1C</xref>), and 31.2&#x2005;pg/mL (<xref ref-type="fig" rid="f01">Figure 1D</xref>).</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>IFN-&#x3B3; and IL-10 levels in PBMC culture supernatants estimated by ELISA. <italic>A, B,</italic> IFN-&#x3B3; levels in PBMC cultures in the presence of <italic>Mycobacterium leprae</italic> and <italic>Leishmania braziliensis</italic> whole antigen extracts (Ml and Lb, respectively), concanavalin A (ConA), and neutralizing anti-IL-10 antibody (anti-IL-10), alone or in combination. <italic>C</italic>, <italic>D</italic>, IL-10 levels in cultures stimulated with Ml alone or with Lb, in the presence or absence of anti-IL-10. <italic>A, C,</italic> During active leprosy; <italic>B</italic>, <italic>D</italic>, after cure of leprosy. The results shown represent the differences between the levels obtained in stimulated and unstimulated cultures (with medium alone). IFN-&#x3B3; = interferon-&#x3B3;; IL-10 = interleukin-10; PBMC = peripheral blood mononuclear cells; ND = not done.</title></caption><graphic xlink:href="0100-879X-bjmbr-45-07-632-gf01"/></fig>
</p>
      <p id="para7">We investigated whether the <italic>M. leprae</italic> antigens could inhibit the IFN-&#x3B3; production stimulated by <italic>L. braziliensis</italic> antigens. This was indeed the case in the two experiments performed before the cure of leprosy, when cultures stimulated with both antigen preparations produced less than one third of the amount of IFN-&#x3B3; measured in supernatants of cultures stimulated with <italic>L. braziliensis</italic> antigens alone. <xref ref-type="fig" rid="f01">Figure 1A</xref> shows the results of one of these experiments. In an experiment performed only once, the <italic>M. leprae</italic> antigens were unable to inhibit the production of IFN-&#x3B3; induced by ConA, and the addition of neutralizing anti-IL-10 antibodies had no effect on the IFN-&#x3B3; levels in this particular experiment (data not shown).</p>
      <p id="para8">The <italic>M. leprae</italic> antigen-induced suppression of the IFN-&#x3B3; response to the <italic>L. braziliensis</italic> extract observed before the cure of leprosy was blocked by neutralizing anti-IL-10 antibodies (<xref ref-type="fig" rid="f01">Figure 1A</xref>). Interestingly enough, the suppressive effect of <italic>M. leprae</italic> antigens in the <italic>L. braziliensis</italic> antigen-induced IFN-&#x3B3; production could not be seen after the cure of leprosy, when the cultures stimulated with both antigen preparations produced as much IFN-&#x3B3; as the cultures stimulated with <italic>L. braziliensis</italic> antigens alone. <xref ref-type="fig" rid="f01">Figure 1B</xref> shows the results of one of two experiments with similar results performed after the cure of leprosy. The loss of the <italic>M. leprae</italic> antigen-induced suppression of the IFN-&#x3B3; response to <italic>L. braziliensis</italic> antigens observed <italic>in vitro</italic> was clinically accompanied by the reactivation and exacerbation of mucosal leishmaniasis (<xref ref-type="fig" rid="f02">Figure 2</xref>).</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2.</label><caption><title>Clinical appearance of the leishmaniasis mucosal lesion. <italic>A</italic>, During active leprosy. <italic>B</italic>, Exacerbation after the cure of leprosy.</title></caption><graphic xlink:href="0100-879X-bjmbr-45-07-632-gf02"/></fig>
</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p id="para9">The high production of IFN-&#x3B3; after stimulation with <italic>L. braziliensis</italic> antigens and the absence of this cytokine after stimulation with <italic>M. leprae</italic> antigens observed both before and after the cure of leprosy are in accordance with previous results obtained with this patient (<xref ref-type="bibr" rid="B06">6</xref>). The absence of an IFN-&#x3B3; response to the <italic>M. leprae</italic> antigen extract was not due to IL-10-mediated suppression since neutralization of IL-10 did not change the inability of the patient's cells to produce IFN-&#x3B3; in response to <italic>M. leprae</italic> antigens, as previously reported (<xref ref-type="bibr" rid="B06">6</xref>). During active leprosy, <italic>M. leprae</italic> antigens were able to markedly inhibit the IFN-&#x3B3; production in <italic>Leishmania</italic> antigen-stimulated PBMC cultures, which was restored by the addition of neutralizing anti-IL-10 antibodies, indicating that this cytokine plays a role in the observed immunosuppression. The down-regulatory effect of the <italic>M. leprae</italic> antigens on the IFN-&#x3B3; response induced by <italic>Leishmania</italic> antigens was completely lost after the cure of leprosy, and the loss of this effect was accompanied by worsening of mucosal leishmaniasis lesions. Besides IL-10, other factors and cells such as IL-4, indoleamine 2, 3-dioxygenase and CD8<sup>+</sup>T cells have also been suggested to participate in the specific T-cell anergy found in patients with lepromatous leprosy (<xref ref-type="bibr" rid="B02">2</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>). Although we cannot rule out the participation of other suppressive mechanisms that could be absent after the healing of leprosy, it is possible that the exacerbation of mucosal leishmaniasis was responsible for the lack of responsiveness to the IL-10-induced suppression of IFN-&#x3B3; production. It has been reported that PBMC from mucosal leishmaniasis patients are poorly responsive to IL-10-mediated suppression of IFN-&#x3B3; production (<xref ref-type="bibr" rid="B14">14</xref>). It should be noted that, in contrast to the reactivation of the mucosal lesion seen when the experiments were performed after the cure of leprosy, the patient was clinically cured of mucosal leishmaniasis when the previous experiments were performed before the cure of leprosy.</p>
      <p id="para10">Taken together, these observations indicate that coinfection with <italic>M. leprae</italic> interfered with the course of mucosal leishmaniasis. Lepromatous leprosy is characterized by the absence of specific cellular immunity to <italic>M. leprae</italic>, resulting in uncontrolled proliferation of bacilli (<xref ref-type="bibr" rid="B12">12</xref>). A number of factors have been implicated as causes of the specific T-cell anergy found in patients with lepromatous leprosy, including CD8<sup>+</sup> and regulatory T cells, IL-4 and IL-10 (<xref ref-type="bibr" rid="B02">2</xref>,<xref ref-type="bibr" rid="B03">3</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>). However, we have found that neutralization of IL-10 did not increase the production of IFN-&#x3B3; in <italic>M. leprae</italic> antigen-stimulated cultures of PBMCs from this multibacillary patient, indicating that the lack of IFN-&#x3B3; production by the patient's T cells was not due to IL-10-mediated suppression. Mucosal leishmaniasis patients have up-regulated IFN-&#x3B3; and TNF-&#x3B1; secretion and decreased IL-10 secretion when compared to patients with uncomplicated cutaneous leishmaniasis (<xref ref-type="bibr" rid="B04">4</xref>). It has been shown that mucosal leishmaniasis lesions possess a higher number of IFN-&#x3B3;-producing cells compared to cutaneous leishmaniasis lesions. Here and in a previously published article (<xref ref-type="bibr" rid="B06">6</xref>) we showed that the IFN-&#x3B3; response of this patient to <italic>Leishmania</italic> antigens was remarkably high, as expected in mucosal leishmaniasis patients. It was even higher than the response obtained with polyclonal stimulation using ConA (<xref ref-type="fig" rid="f01">Figure 1A</xref> and <xref ref-type="fig" rid="f01">1B</xref>). This result agrees with the data shown in our previous study with this patient, in which the levels of proinflammatory cytokines (IFN-&#x3B3; and TNF-&#x3B1;) were higher with <italic>Leishmania</italic> antigen stimulation than with ConA stimulation (<xref ref-type="bibr" rid="B06">6</xref>).</p>
      <p id="para11">Moreover, a decreased <italic>in situ</italic> expression of the IL-10 receptor was proposed as a possible mechanism for the exacerbated inflammatory and cytotoxic responses involved in tissue damage in the mucosal lesions caused by <italic>L. braziliensis</italic> infection (<xref ref-type="bibr" rid="B16">16</xref>). IL-10 is a potent inhibitor of the production of cytokines involved in the inflammatory response, such as TNF-&#x3B1;, IL-1, IFN-&#x3B3;, and IL-12 (<xref ref-type="bibr" rid="B17">17</xref>). There is solid evidence that live <italic>L. braziliensis</italic> parasites persist after the clinical cure of American tegumentary leishmaniasis (<xref ref-type="bibr" rid="B18">18</xref>). Relapse of leishmaniasis mucosal lesions is frequent (<xref ref-type="bibr" rid="B19">19</xref>) and is a challenge for clinicians. Recently, local immunological factors associated with recurrence of mucosal leishmaniasis were described using immunohistochemical analysis of cell phenotypes and cytokines present in the inflammatory infiltrate of mucosal lesions. IFN-&#x3B3;-producing cells were detected in active lesions and decreased after therapy (<xref ref-type="bibr" rid="B19">19</xref>). On the other hand, IL-10 expression was markedly increased in cured patients. These observations suggest that IL-10 plays a role in the control of pathology in mucosal leishmaniasis.</p>
      <p id="para12">Most reports on immunomodulation during coinfection refer to associated HIV/AIDS infections. It has also been shown that helminth infections can induce immunomodulation and interfere with the course of several infectious diseases (<xref ref-type="bibr" rid="B20">20</xref>), including leprosy (<xref ref-type="bibr" rid="B21">21</xref>) and leishmaniasis (<xref ref-type="bibr" rid="B22">22</xref>). Interestingly, the influence of this association with helminthic infections may either be beneficial or deleterious to the clinical course of protozoan diseases such as malaria (<xref ref-type="bibr" rid="B20">20</xref>).</p>
      <p id="para13">Studies on the association of leprosy and leishmaniasis are rare, and, to our knowledge, in this coinfection, this is the first report of the influence of one infection (with <italic>M. leprae</italic>) on the immune response to the other pathogen (<italic>L. braziliensis</italic>) and on the clinical course of the disease caused by it (mucosal leishmaniasis). Our results indicate that concomitant leprosy induced an IL-10-mediated regulatory response that might have controlled the immunopathology of mucosal leishmaniasis. It should be remembered, however, that this patient had an unusual association of two opposite polar forms of these spectral diseases: lepromatous leprosy (anergic, multibacillary) and mucosal leishmaniasis (hyperergic, pauciparasitic). The study of other cases of association of leprosy and tegumentary leishmaniasis may increase our knowledge about the interference that one infection can have on the immunopathogenesis and clinical course of the other.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p id="para14">S.C.F. Mendon&#xE7;a is the recipient of a fellowship as a CNPq investigator.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akuffo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Maasho</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Blostedt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hojeberg</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Britton</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bakhiet</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title><italic>Leishmania aethiopica</italic> derived from diffuse leishmaniasis patients preferentially induce mRNA for interleukin-10 while those from localized leishmaniasis patients induce interferon-gamma</article-title>
          <source>J Infect Dis</source>
          <year>1997</year>
          <volume>175</volume>
          <fpage>737</fpage>
          <lpage>741</lpage>
          <pub-id pub-id-type="pmid">9041358</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sieling</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Abrams</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Yamamura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Salgame</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bloom</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Rea</surname>
              <given-names>TH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Immunosuppressive roles for IL-10 and IL-4 in human infection. <italic>In vitro</italic> modulation of T cell responses in leprosy</article-title>
          <source>J Immunol</source>
          <year>1993</year>
          <volume>150</volume>
          <fpage>5501</fpage>
          <lpage>5510</lpage>
          <pub-id pub-id-type="pmid">8515073</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Modlin</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Th1-Th2 paradigm: insights from leprosy</article-title>
          <source>J Invest Dermatol</source>
          <year>1994</year>
          <volume>102</volume>
          <fpage>828</fpage>
          <lpage>832</lpage>
          <pub-id pub-id-type="pmid">8006444</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bacellar</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Lessa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schriefer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ribeiro de</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Dutra</surname>
              <given-names>WO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Up-regulation of Th1-type responses in mucosal leishmaniasis patients</article-title>
          <source>Infect Immun</source>
          <year>2002</year>
          <volume>70</volume>
          <fpage>6734</fpage>
          <lpage>6740</lpage>
          <pub-id pub-id-type="pmid">12438348</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delobel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Launois</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Djossou</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sainte-Marie</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pradinaud</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>American cutaneous leishmaniasis, lepromatous leprosy, and pulmonary tuberculosis coinfection with downregulation of the T-helper 1 cell response</article-title>
          <source>Clin Infect Dis</source>
          <year>2003</year>
          <volume>37</volume>
          <fpage>628</fpage>
          <lpage>633</lpage>
          <pub-id pub-id-type="pmid">12942392</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matos</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Azeredo-Coutinho</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Schubach</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Concei&#xE7;&#xE3;o-Silva</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Baptista</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Moreira</surname>
              <given-names>JS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential interferongamma production characterizes the cytokine responses to <italic>Leishmania</italic> and <italic>Mycobacterium leprae</italic> antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy</article-title>
          <source>Clin Infect Dis</source>
          <year>2005</year>
          <volume>40</volume>
          <fpage>e5</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">15655736</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cupolillo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Grimaldi</surname>
              <given-names>G</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Momen</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A general classification of New World <italic>Leishmania</italic> using numerical zymotaxonomy</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>1994</year>
          <volume>50</volume>
          <fpage>296</fpage>
          <lpage>311</lpage>
          <pub-id pub-id-type="pmid">8147488</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicolle</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Culture des corps de Leishman isol&#xE9;s de la rate dans trois cas d'an&#xE9;mie splenique infantile</article-title>
          <source>Bull Soc Pathol Exot</source>
          <year>1908</year>
          <volume>1</volume>
          <fpage>121</fpage>
          <lpage>126</lpage>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Telino</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>De Luca</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Matos</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Azeredo-Coutinho</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Meirelles</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Concei&#xE7;&#xE3;o-Silva</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>In vitro</italic> responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of <italic>Leishmania</italic> promastigotes</article-title>
          <source>Clin Exp Immunol</source>
          <year>2006</year>
          <volume>143</volume>
          <fpage>338</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="pmid">16412059</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matta</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Nogueira</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>de Souza</surname>
              <given-names>E Souza</given-names>
            </name>
            <name>
              <surname>Mattos</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Oliveira-Neto</surname>
              <given-names>MP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Leishmania</italic> (<italic>Viannia</italic>) <italic>guyanensis</italic> induces low immunologic responsiveness in leishmaniasis patients from an endemic area of the Brazilian Amazon Highland</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2009</year>
          <volume>80</volume>
          <fpage>339</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="pmid">19270278</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lima</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Rumjanek</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Gomes</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Duppre</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sampaio</surname>
              <given-names>EP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Immunological cytokine correlates of protective immunity and pathogenesis in leprosy</article-title>
          <source>Scand J Immunol</source>
          <year>2000</year>
          <volume>51</volume>
          <fpage>419</fpage>
          <lpage>428</lpage>
          <pub-id pub-id-type="pmid">10736116</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salgame</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Modlin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bloom</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
          <article-title>On the mechanism of human T cell suppression</article-title>
          <source>Int Immunol</source>
          <year>1989</year>
          <volume>1</volume>
          <fpage>121</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="pmid">2535060</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Souza Sales</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lara</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Amadeu</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>de Oliveira Fulco</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>da Costa Nery</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Sampaio</surname>
              <given-names>EP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The role of indoleamine 2,3-dioxygenase in lepromatous leprosy immunosuppression</article-title>
          <source>Clin Exp Immunol</source>
          <year>2011</year>
          <volume>165</volume>
          <fpage>251</fpage>
          <lpage>263</lpage>
          <pub-id pub-id-type="pmid">21592112</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carvalho</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Passos</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dutra</surname>
              <given-names>WO</given-names>
            </name>
            <name>
              <surname>Soto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alonso</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gollob</surname>
              <given-names>KJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients</article-title>
          <source>Scand J Immunol</source>
          <year>2005</year>
          <volume>61</volume>
          <fpage>337</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="pmid">15853916</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Britton</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Lockwood</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>Leprosy</article-title>
          <source>Lancet</source>
          <year>2004</year>
          <volume>363</volume>
          <fpage>1209</fpage>
          <lpage>1219</lpage>
          <pub-id pub-id-type="pmid">15081655</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faria</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Gollob</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Barbosa</surname>
              <given-names>J</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Schriefer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Lessa</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Decreased <italic>in situ</italic> expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis</article-title>
          <source>Infect Immun</source>
          <year>2005</year>
          <volume>73</volume>
          <fpage>7853</fpage>
          <lpage>7859</lpage>
          <pub-id pub-id-type="pmid">16299275</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D'Andrea</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aste-Amezaga</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Valiante</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Kubin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Trinchieri</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells</article-title>
          <source>J Exp Med</source>
          <year>1993</year>
          <volume>178</volume>
          <fpage>1041</fpage>
          <lpage>1048</lpage>
          <pub-id pub-id-type="pmid">8102388</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schubach</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cuzzi-Maya</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Sartori</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>de Oliveira-Neto</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Mattos</surname>
              <given-names>MS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Leishmanial antigens in the diagnosis of active lesions and ancient scars of American tegumentary leishmaniasis patients</article-title>
          <source>Mem Inst Oswaldo Cruz</source>
          <year>2001</year>
          <volume>96</volume>
          <fpage>987</fpage>
          <lpage>996</lpage>
          <pub-id pub-id-type="pmid">11685267</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tuon</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Gomes-Silva</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Da-Cruz</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Duarte</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Neto</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Amato</surname>
              <given-names>VS</given-names>
            </name>
          </person-group>
          <article-title>Local immunological factors associated with recurrence of mucosal leishmaniasis</article-title>
          <source>Clin Immunol</source>
          <year>2008</year>
          <volume>128</volume>
          <fpage>442</fpage>
          <lpage>446</lpage>
          <pub-id pub-id-type="pmid">18585959</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Riet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hartgers</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Yazdanbakhsh</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Chronic helminth infections induce immunomodulation: consequences and mechanisms</article-title>
          <source>Immunobiology</source>
          <year>2007</year>
          <volume>212</volume>
          <fpage>475</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="pmid">17544832</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diniz</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Zandonade</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dietze</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Ribeiro-Rodrigues</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Short report: do intestinal nematodes increase the risk for multibacillary leprosy?</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2001</year>
          <volume>65</volume>
          <fpage>852</fpage>
          <lpage>854</lpage>
          <pub-id pub-id-type="pmid">11791986</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Neal</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Guimar&#xE3;es</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Alc&#xE2;ntara</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Passos</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Influence of helminth infections on the clinical course of and immune response to <italic>Leishmania braziliensis</italic> cutaneous leishmaniasis</article-title>
          <source>J Infect Dis</source>
          <year>2007</year>
          <volume>195</volume>
          <fpage>142</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="pmid">17152018</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
